Jimmy K. Limdi

ORCID: 0000-0002-1039-6251 · 1 paper in corpus
article 2019
·doi:10.1136/gutjnl-2019-bsgabstracts.390

Introduction Despite advances in Ulcerative Colitis (UC) therapies, many patients suffer refractory symptoms in the absence of active inflammation. For this group, treatment remains challenging, with a paucity of therapeutic options. In thi…